ANEB · Anebulo Pharmaceuticals, Inc.
Market Cap
$13.46M
Shares
40.78M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$8.48M
-3.5%
FY2025
Diluted EPS
-$0.25
+21.9%
FY2025
Operating Cash Flow
-$6.35M
+21.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $3.74M | $4.3M | $3.55M | $5.6M | $2.96M | $2.27M | |
| $5.36M | $4.92M | $4.76M | $6.18M | $3.87M | $1.34M | |
| $9.1M | $9.22M | $8.31M | $11.78M | $6.83M | $3.61M | |
| -$9.1M | -$9.22M | -$8.31M | -$11.78M | -$6.83M | -$3.61M | |
| $234K | $400K | $200K | — | — | $11.77K | |
| — | — | — | — | — | $1020 | |
| $1.12M | $738.72K | $107.05K | $51.26K | $5555 | -$26.64M | |
| — | — | — | — | — | -$3.61M | |
| -$7.98M | -$8.48M | -$8.2M | -$11.73M | -$6.83M | -$30.25M | |
| — | — | — | — | -$6.83M | -$38.46M | |
| USD/shares | -$0.18 | -$0.25 | -$0.32 | -$0.47 | $0.29 | -$2.83 |
| USD/shares | -$0.18 | -$0.25 | -$0.32 | -$0.47 | $0.29 | — |
| shares | — | 33.82M | 25.82M | 25.07M | 23.34M | 13.61M |
| shares | — | 33.82M | 25.82M | 25.07M | 23.34M | 13.61M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.